THE THROMBOSIS RESEARCH INSTITUTE

Registered charity 800365 · accounts filings on the Charity Commission register

Get email alerts for this charity

Latest income
£3.4m
Latest spending
£3.2m
Registered
1988
Accounts read
FY2023

Financial health, per its FY2023 accounts

The accounts state that unrestricted reserves stood at £7,010,689 against an annual unrestricted expenditure of £3,206,079, providing a reserve ratio of approximately 2.2 years. The Trustees consider the financial health of the Institute to be good, noting that it continues to attract funds to support its research and educational activities despite a net expenditure for the year.

What the accounts disclose

Highest-paid employee band: £190,001 - £200,000 — above the 90th percentile for charities its size (median £70k)
In the band £190,001 - £200,000 — page 31
Per its FY2023 accounts as filed with the Charity Commission.
Employees paid over £60,000: 11
Total amount paid to key management staff was £537,630 — page 31
Per its FY2023 accounts as filed with the Charity Commission.
Related-party transaction: Patrick Burgess, a Trustee of the Institute, was also a Trustee of the Thrombosis Research Trust (charity number 275275), which supports the Institute.
At the year-end, Patrick Burgess was a Trustee of the Institute and the Thrombosis Research Trust. — page 5
Per its FY2023 accounts as filed with the Charity Commission.
Trading subsidiary: TRI Technology Transfer Limited, TRI Clinical Trials Limited
subsidiary undertakings as follows: TRI Technology Transfer Limited (intellectual property) TRI Clinical Trials Limited (research and development)
Per its FY2023 accounts as filed with the Charity Commission.

Accounts audited by Haysmacintyre LLP. Discloses 5 of 6 completeness components.

Structured financials (annual return, FY ending 31/07/2025)

Total income
£3.4m
Total spending
£3.2m
Reserves (reported)
£10.1m
Employees
17

Reported reserves equal ~37.5 months of spending — in the top quarter for charities its size (median 4.8 months; benchmarks).

Trustees

Trustee list from the Charity Commission register (current, not historical).

Operates in: Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/07/2025£3.4m£3.2m
31/07/2024£3.1m£2.9m
31/07/2023£1.7m£3.2m
31/07/2022£3.5m£4.4m
31/07/2021£3.3m£6.9m

Common questions

Is THE THROMBOSIS RESEARCH INSTITUTE financially healthy?

The accounts state that unrestricted reserves stood at £7,010,689 against an annual unrestricted expenditure of £3,206,079, providing a reserve ratio of approximately 2.2 years. The Trustees consider the financial health of the Institute to be good, noting that it continues to attract funds to support its research and educational activities despite a net expenditure for the year. Its FY2023 accounts were audited by Haysmacintyre LLP.

What does the highest-paid employee of THE THROMBOSIS RESEARCH INSTITUTE earn?

Per its FY2023 accounts, the highest-paid employee was in the £190,001 - £200,000 band, and 11 employees earned over £60,000.